Northside Hospital,Inc.- Central Research Department

Atlanta, Georgia 30342

0 studies enrolling now · 6 studies all time

What they study most

Advanced Breast Cancer, Advanced Gastric Cancer, Breast Cancer, Breast Neoplasms, Cancer, Chronic Myeloid Leukemia, Gastroesophageal Junction Adenocarcinoma, Genes, BRCA 1, HER2 Low Breast Neoplasms, HER2 Positive Breast Cancer, HER2 Positive Breast Neoplasms, HER2-positive Breast Cancer

Studies at this site

• A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer — Running, not enrolling
• A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors — Running, not enrolling
• A Study of Tucatinib Plus Trastuzumab Deruxtecan in HER2+ Breast Cancer — Completed
• Javelin BRCA/ATM: Avelumab Plus Talazoparib in Patients With BRCA or ATM Mutant Solid Tumors — Stopped early
• A Study of Neoadjuvant Nivolumab + Palbociclib + Anastrozole in Post-Menopausal Women and Men With Primary Breast Cancer — Completed
• Bosutinib Treatment Extension Study Only For Subjects With Chronic Myeloid Leukemia (CML) Who Have Previously Participated In Bosutinib Studies B1871006 Or B1871008 — Completed